STX-478
Modify Date: 2024-03-12 22:26:54
STX-478 structure
|
Common Name | STX-478 | ||
|---|---|---|---|---|
| CAS Number | 2883540-92-7 | Molecular Weight | 401.29 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H12F5N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of STX-478STX-478 (compound 80) is an oral CNS-penetrant allosteric mutant-selective PI3Kα inhibitor. STX-478 STX-478 shows robust and durable tumor regression and can be used in cancer research[1]. |
| Name | STX-478 |
|---|
| Description | STX-478 (compound 80) is an oral CNS-penetrant allosteric mutant-selective PI3Kα inhibitor. STX-478 STX-478 shows robust and durable tumor regression and can be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
PI3Kα[1]. |
| References |
[1]. JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1. |
| Molecular Formula | C16H12F5N5O2 |
|---|---|
| Molecular Weight | 401.29 |